Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works citing this work

2 works

Work: Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

  1. COVID-19 Vaccines - Current State and Perspectives

    Ibrokhim Y. Abdurakhmonov

    BookSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks20221 citations
    ABI

  2. Cellular vesicles-based “all-in-one” vaccine platform triggers mucosal immunity against respiratory viruses

    Yanrong Gao, Jie Zhu, Jimao Zhai +7

    ArticleBacterial Infections and VaccinesNano Today20240 citations
    ABI